Severe pulmonary hypertension in patients with emphysema but preserved FEV1: Prognosis and response to treatment

M. Brewis, A. Church, A. Peacock, M. Johnson (Glasgow, United Kingdom)

Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Session: Pulmonary circulation: clinical pulmonary hypertension I
Session type: Thematic Poster Session
Number: 2620
Disease area: Pulmonary vascular diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Brewis, A. Church, A. Peacock, M. Johnson (Glasgow, United Kingdom). Severe pulmonary hypertension in patients with emphysema but preserved FEV1: Prognosis and response to treatment. Eur Respir J 2013; 42: Suppl. 57, 2620

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Effect of long-term treatment with fenspiride on clinical and functional status of patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013


Usefulness of admission red cell distribution Width as a predictor of early mortality in patients with severe exacerbation of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

Acute and chronic effects of PDE5-Is on SpO2 in patients with COPD associated pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical treatment
Year: 2013


COPD and clinical phenotypes: Patients with concomitant pulmonary hypertension may be less likely to be frequent exacerbators
Source: International Congress 2014 – Clinical presentations
Year: 2014

Effects of pulmonary rehabilitation in patients with severe COPD in comparison to patients with severe interstitial lung disease
Source: Annual Congress 2013 –The best posters in pulmonary rehabilitation
Year: 2013


Pulmonary diffusing capacity and the risk of fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD markers
Year: 2014

Unilateral treatment with lung volume reduction coils in patients with severe emphysema
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013

Diagnosis and treatment of secondary pulmonary hypertension in patients with COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 404s
Year: 2006

Tiotropium in chronic obstructive pulmonary disease: Gender differences in outcomes
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016


Right ventricular response during exercise in patients with chronic obstructive pulmonary disease
Source: International Congress 2015 – Clinical exercise physiology in health and disease
Year: 2015

Frequency of osteoporosis and pulmonary diffusing capacity in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2014 – COPD: points to ponder
Year: 2014

Impact of atelectasis on survival in emphysema patients treated with bronchoscopic lung volume reduction
Source: Annual Congress 2013 –Bronchoscopic treatment of COPD and asthma: where are we going?
Year: 2013


Hyperglycemia is associated with poor outcomes in patients with acute exacerbations of chronic obstructive pulmonary disease
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013

NT-proBNP in assessment of pulmonary hypertension in COPD patients
Source: Annual Congress 2013 –COPD treatment
Year: 2013

Conclusion: treatment of pulmonary hypertension in COPD patients
Source: Annual Congress 2005 - COPD - pulmonary haemodynamics and gas exchange
Year: 2005

The prevalence and characteristics of pulmonary hypertension in severe COPD
Source: International Congress 2016 – Pulmonary hypertension in lung disease
Year: 2016


Impact of exacerbations on pulmonary arterial enlargement in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013

Oscillating positive expiratory pressure (oPEP) therapy in chronic obstructive pulmonary disease and bronchiectasis
Source: International Congress 2014 – Best posters in chronic care
Year: 2014

Prognostic impact of chronic obstructive pulmonary disease in severe symptomatic aortic stenosis
Source: International Congress 2016 – Recent high impact findings regarding COPD comorbidities
Year: 2016

Changes in inhalation therapy after combined assessment of COPD
Source: International Congress 2015 – COPD: exacerbations, gas exchange and associated dysfunction
Year: 2015